Previous Article | Next Article ![]()
Infection and Immunity, June 2004, p. 3331-3335, Vol. 72, No. 6
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.6.3331-3335.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts,1 Wellcome Trust/KEMRI Centre for Geographic Medicine Research-Coast, Kilifi, Kenya,2 Nuffield Department of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Headington, United Kingdom3
Received 25 November 2003/ Returned for modification 5 February 2004/ Accepted 3 March 2004
Streptococcus pneumoniae is the primary etiological agent of community-acquired pneumonia and a major cause of meningitis and bacteremia. Three conserved pneumococcal proteinspneumolysin, pneumococcal surface adhesin A (PsaA), and pneumococcal surface protein A (PspA)are currently being investigated as vaccine candidates. Such protein-based vaccines, if proven effective, could provide a cheaper alternative to conjugate vaccine formulae. Few data from sub-Saharan Africa exist concerning the development of natural antibody to these antigens, however. To investigate the age-specific development of antiprotein immunoglobulin G (IgG) and IgA antibody responses, the sera of 220 persons 2 weeks to 84 years of age from coastal Kenya were assayed using enzyme-linked immunosorbent assays. IgG and IgA antibody responses to each antigen were observed in all age groups. Serum concentrations of IgG and IgA antibody responses to PspA and PdB (a recombinant toxoid derivative of pneumolysin), but not to PsaA, increased significantly with age (P < 0.001). No decline was observed in the sera of the elderly. Anti-protein IgG concentrations were only weakly correlated (0.30 < r < 0.56; P < 0.0001), as were IgA concentrations (0.24 < r < 0.54; P < 0.0001).
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|